Results

Total Results: 1,070 records

Showing results for "analyze".

21. Urinary-Incontinence-Treatment Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
    September 30, 2010 - We will analyze the harmful effects of drugs from all sources including efficacy, effectiveness, and … We will analyze harms regardless of how authors perceived causality of the study treatments. … We will analyze urinary incontinence with the definitions of signs and symptoms of UI promoted by the … We will also analyze urinary continence defined as negative stress and pad tests. … We will analyze in logarithmic scale adjusted regression coefficient with standard error of association

22. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

23. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
    January 01, 2024 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

24. App-E-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…

25. Cer-250-Cannabis-2025-Surv-Rep-Update-Tables-E1-4 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
    January 01, 2025 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…

26. Microsoft Word - cognitive-decline-protocol-160322.docx (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - We will therefore group studies in the most appropriate way possible and analyze data for specific subgroups … When sufficient trial data are not available, we will analyze high quality observational studies of … As noted above, we will separately analyze studies by the average age of the subjects enrolled and study … If certain comparisons can be pooled, we will meta-analyze the data using a random effects model.

27. S3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
    October 01, 2007 - selected into the highly coveted UNC Pediatrics resident program had mastered, but also had an ability to analyze

28. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…

29. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…

30. Cancer-Anemia-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - 1 Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update Executive Summary Background Anemia, a deficiency in the concentration of hemoglobin-containing red blood cells, is prevalent among cancer patients, depending on the type of malignancy and t…

31. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
    December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening APPENDIX A FDA STATUS- SCREENING DEVICES SE: Substantially equivalent; Premarket notification, 501(k) Page 1 of 19 Ophthalmoscope, AC-powered Product code: HLI COMPANY PRODUCT FDA STATUS* APPROVAL DATE ACCUTECH MEDICAL TECHNOLOGIES IN…

32. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
    December 23, 2009 - Appendix A2: FDA status of medical devices for glaucoma screening APPENDIX A FDA STATUS- SCREENING DEVICES SE: Substantially equivalent; Premarket notification, 501(k) Page 1 of 19 Ophthalmoscope, AC-powered Product code: HLI COMPANY PRODUCT FDA STATUS* APPROVAL DATE ACCUTECH MEDICAL TECHNOLOGIES IN…

33. Methods Guide for Medical Test Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-metaanalysis_methods.pdf
    July 01, 2012 - Recommended Approaches Which Metrics to Meta-Analyze For each study, the estimates of sensitivity … Why does it make sense to directly meta-analyze sensitivity and specificity? … Why does it not make sense to directly meta-analyze positive and negative predictive values or prevalence … Specifically, Dukic and Gatsonis extended the HSROC model to analyze sensitivity and specificity data

34. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
    September 30, 2015 - Appendix Table D-1. RCTs Table D-1. Randomized controlled trials Author, Year Study Design Duration Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality Hruschak, 2021 RCT Duration:…

35. Executive Summary_Systematic Review: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
    March 01, 2025 - Executive Summary_Systematic Review: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition Systematic Review Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition Execu…

36. A Prospective Comparison of Evidence Synthesis Search Strategies Developed With and Without Text-Mining Tools (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-results-search-strategies-developed-with-without-text-mining-tools.pdf
    March 01, 2021 - Text-Mining Tools Many software programs analyze textual documents and bibliographic citations.10, 11 … Subject Term Tool | Web-Based Tool) MeSH on Demand is a National Library of Medicine (NLM) designed to analyze … Very quick to analyze text (took seconds to get my subject headings). … Very quick to analyze text (took seconds to get my subject headings).

37. Disposition of comments_Comparative Effectiveness Review No. 242: Radiation Therapy for Brain Metastases (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-disposition-comments.pdf
    June 09, 2021 - This limited our ability to analyze these findings for this systematic review https://effectivehealthcare.ahrq.gov … analyses based on tumor type or other factors, we do not have the patient-level data required to analyze … While the systematic review was limited in the ability to analyze these factors, a number of influential … mentioned (histologic subtype, tumor number and tumor volume) were abstracted, however the ability to analyze … inconsistent and often lacked sufficient detail (mean and standard deviation), limiting the ability to analyze

38. S166 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s166.pdf
    October 01, 2007 - well-defined Bayesian hierarchical models proposed by Smith et al,7 Bayesian approaches can be used to analyze

39. Arcia-notes-Teresa (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arcia-presentation.pdf
    May 29, 2025 -  be capturing al of the user actions in the system logs that we can later download the log files to analyze … Also, if we could analyze the log files as people are using the tool, could  use their usage patterns

40. Web Interactive Presentation of EPC Reports: A Foray Into Interactive Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
    September 01, 2019 - need is technical, and pertains to developing a unified way to represent, manipulate, describe, meta-analyze … Mathematical graphs are a very versatile modeling tool,15 and they are used to describe, analyze, and